Clinical Trials Logo

Clinical Trial Summary

The study is designed to determine the efficacy of the Cupola tattoo removal device for tattoo removal.


Clinical Trial Description

The Cupola system is a non-invasive device for pigment/tattoo removal based on ultrasound technology. The safety of the device was demonstrated in a previous pilot study approved by the Herzog Helsinki committee #167-09, Ministry of Health April 2010 #HT-5293) showing that no risk was associated with the procedure.

This study is designed to determine the efficacy of the device for tattoo removal in up to 6 treatments in different treatment intervals. Three areas of the tattoo that are similar in size, color, and intensity will be chosen. One area will not be treated; the second will receive 6 treatments in 2-3 week intervals; the third will receive 3 treatments in 4-6 week intervals. The evaluations will include color measurements, photography, subject comfort and skin condition. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01516034
Study type Interventional
Source Cupola Medical Ltd
Contact
Status Terminated
Phase N/A
Start date November 2011
Completion date November 2012

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05371795 - Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device N/A
Completed NCT06132295 - Adoption of Multiple Strategies to Reduce the Rate of Marker Detachment During Radiotherapy in Patients With Cancer N/A
Completed NCT03125824 - Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol N/A